Lee Financial’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-18
| Closed | -$1.25K | – | 877 |
|
2023
Q3 | $1.25K | Hold |
18
| – | – | ﹤0.01% | 758 |
|
2023
Q2 | $1.7K | Buy |
+18
| New | +$1.7K | ﹤0.01% | 684 |
|
2022
Q4 | – | Sell |
-7
| Closed | -$1K | – | 949 |
|
2022
Q3 | $1K | Sell |
7
-271
| -97% | -$38.7K | ﹤0.01% | 754 |
|
2022
Q2 | $26K | Sell |
278
-13
| -4% | -$1.22K | ﹤0.01% | 303 |
|
2022
Q1 | $34K | Buy |
291
+22
| +8% | +$2.57K | 0.01% | 275 |
|
2021
Q4 | $35K | Buy |
269
+5
| +2% | +$651 | 0.01% | 292 |
|
2021
Q3 | $30K | Hold |
264
| – | – | 0.01% | 277 |
|
2021
Q2 | $27K | Hold |
264
| – | – | 0.01% | 284 |
|
2021
Q1 | $22K | Hold |
264
| – | – | 0.01% | 295 |
|
2020
Q4 | $24K | Hold |
264
| – | – | 0.01% | 266 |
|
2020
Q3 | $21K | Hold |
264
| – | – | 0.01% | 303 |
|
2020
Q2 | $18K | Hold |
264
| – | – | 0.01% | 287 |
|
2020
Q1 | $17K | Hold |
264
| – | – | 0.01% | 240 |
|
2019
Q4 | $21K | Hold |
264
| – | – | ﹤0.01% | 251 |
|
2019
Q3 | $19K | Hold |
264
| – | – | ﹤0.01% | 255 |
|
2019
Q2 | $16K | Hold |
264
| – | – | ﹤0.01% | 285 |
|
2019
Q1 | $17K | Hold |
264
| – | – | ﹤0.01% | 267 |
|
2018
Q4 | $13K | Hold |
264
| – | – | ﹤0.01% | 253 |
|
2018
Q3 | $15K | Hold |
264
| – | – | ﹤0.01% | 277 |
|
2018
Q2 | $13K | Hold |
264
| – | – | ﹤0.01% | 429 |
|
2018
Q1 | $12K | Hold |
264
| – | – | ﹤0.01% | 437 |
|
2017
Q4 | $10K | Hold |
264
| – | – | ﹤0.01% | 322 |
|
2017
Q3 | $10K | Hold |
264
| – | – | ﹤0.01% | 329 |
|
2017
Q2 | $10K | Hold |
264
| – | – | ﹤0.01% | 316 |
|
2017
Q1 | $8K | Hold |
264
| – | – | ﹤0.01% | 306 |
|
2016
Q4 | $8K | Buy |
+264
| New | +$8K | ﹤0.01% | 320 |
|